Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ciprofloxacin or amoxicillin exposure in febrile versus afebrile hospitalized patients
NL-OMON23093Not yet recruiting
- Sponsor
- N.A.
- Start
- Jun 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ciprofloxacin and amoxicillin in bacterial disease (2 cohorts), sponsored by N.A. Primary endpoint: AUC. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
ciprofloxacinamoxicillin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON23093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23093.